Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia

被引:92
|
作者
Ryan, Michael B. [1 ,2 ,3 ]
Bair-Marshall, Chloe [4 ]
Nelson, Alexandra B. [1 ,2 ,3 ,4 ]
机构
[1] UCSF, Neurosci Grad Program, San Francisco, CA 94158 USA
[2] UCSF, Weill Inst Neurosci, San Francisco, CA 94158 USA
[3] UCSF, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA
[4] UCSF, Dept Neurol, San Francisco, CA 94158 USA
来源
CELL REPORTS | 2018年 / 23卷 / 12期
关键词
DOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; PROJECTION NEURONS; SUBTHALAMIC NUCLEUS; CRE-RECOMBINASE; DISEASE; ACTIVATION; APOMORPHINE; RECORDINGS; PLASTICITY;
D O I
10.1016/j.celrep.2018.05.059
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Action selection relies on the coordinated activity of striatel direct and indirect pathway medium spiny neurons (dMSNs and iMSNs, respectively). Loss of dopamine in Parkinson's disease is thought to disrupt this balance. While dopamine replacement with levodopa may restore normal function, the development of involuntary movements (levodopa-induced dyskinesia [LID]) limits therapy. How chronic dopamine loss and replacement with levodopa modulate the firing of identified MSNs in behaving animals is unknown. Using optogenetically labeled striatel single-unit recordings, we assess circuit dysfunction in parkinsonism and LID. Counter to current models, we found that following dopamine depletion, iMSN firing was elevated only during periods of immobility, while dMSN firing was dramatically and persistently reduced. Most notably, we identified a subpopulation of dMSNs with abnormally high levodopa-evoked firing rates, which correlated specifically with dyskinesia. These findings provide key insights into the circuit mechanisms underlying parkinsonism and LID, with implications for developing targeted therapies.
引用
收藏
页码:3438 / +
页数:14
相关论文
共 50 条
  • [21] Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
    Nakamura, T.
    Nishijima, H.
    Mori, F.
    Kinoshita, I.
    Kon, T.
    Suzuki, C.
    Wakabayashi, K.
    Tomiyama, M.
    MOVEMENT DISORDERS, 2023, 38 : S553 - S554
  • [22] Axon terminal hypertrophy of striatal projection neurons with levodopa-induced dyskinesia priming
    Nakamura, Takashi
    Nishijima, Haruo
    Mori, Fumiaki
    Kinoshita, Iku
    Kon, Tomoya
    Suzuki, Chieko
    Wakabayashi, Koichi
    Tomiyama, Masahiko
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [23] Morphologic Changes of Dendritic Spines of Striatal Neurons in the Levodopa-Induced Dyskinesia Model
    Nishijima, Haruo
    Suzuki, Satoko
    Kon, Tomoya
    Funamizu, Yukihisa
    Ueno, Tatsuya
    Haga, Rie
    Suzuki, Chihiro
    Arai, Akira
    Kimura, Tamaki
    Suzuki, Chieko
    Meguro, Reiko
    Miki, Yasuo
    Yamada, Junko
    Migita, Keisuke
    Ichinohe, Noritaka
    Ueno, Shinya
    Baba, Masayuki
    Tomiyama, Masahiko
    MOVEMENT DISORDERS, 2014, 29 (03) : 336 - 343
  • [24] Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia
    Gardoni, F.
    Morari, M.
    Kulisevsky, J.
    Brugnoli, A.
    Novello, S.
    Pisano, C. A.
    Caccia, C.
    Mellone, M.
    Melloni, E.
    Padoani, G.
    Sosti, V
    Vailati, S.
    Keywood, C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 367 (03): : 442 - 451
  • [25] Automated Levodopa-Induced Dyskinesia Assessment
    Tsipouras, Markos G.
    Tzallas, Alexandros T.
    Rigas, Georgios
    Bougia, Panagiota
    Fotiadis, Dimitrios I.
    Konitsiotis, Spyridon
    2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2010, : 2411 - 2414
  • [27] Neurosurgical Approaches to Levodopa-Induced Dyskinesia
    Martini, Michael L.
    Mocco, J.
    Panov, Fedor
    WORLD NEUROSURGERY, 2019, 126 : 376 - 382
  • [28] Nondopaminergic mechanisms in levodopa-induced dyskinesia
    Brotchie, JA
    MOVEMENT DISORDERS, 2005, 20 (08) : 919 - 931
  • [29] LEVODOPA-INDUCED DYSKINESIA - CLINICAL OBSERVATIONS
    FRIEDMAN, A
    JOURNAL OF NEUROLOGY, 1985, 232 (01) : 29 - 31
  • [30] Emerging drugs for levodopa-induced dyskinesia
    Al Dakheel, Amaal
    Beaulieu-Boire, Isabelle
    Fox, Susan H.
    EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (03) : 415 - 429